Showing results (1101-1110 of 1,193) with videos related to
Sort By:
Pageof 120
Cerebral Cortex (New York, N.Y. : 1991)|October 29, 2020
Structural and Functional Brain Parameters Related to Cognitive Performance Across Development: Replication and Extension of the Parieto-Frontal Integration Theory in a Single SampleRuben C Gur, Ellyn R Butler, Tyler M Moore, et al.Journal for Immunotherapy of Cancer|November 30, 2022
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanomaNikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, et al.European Heart Journal|July 19, 2021
Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compactionSiyeon Rhee, David T Paik, Johnson Y Yang, et al.JAMA|July 24, 2019
Neuroimaging Findings in US Government Personnel With Possible Exposure to Directional Phenomena in Havana, CubaRagini Verma, Randel L Swanson, Drew Parker, et al.ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.Scientific Reports|May 24, 2022
Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastomaAnahita Fathi Kazerooni, Sanjay Saxena, Erik Toorens, et al.BMC Plant Biology|March 31, 2011
Analysis of BAC-end sequences (BESs) and development of BES-SSR markers for genetic mapping and hybrid purity assessment in pigeonpea (Cajanus spp.)Abhishek Bohra, Anuja Dubey, Rachit K Saxena, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic <i>BRAF</i>-Mutant MelanomaJean-Pierre Delord, Caroline Robert, Marta Nyakas, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2019
Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of InfectionGovindakarnavar Arunkumar, Santhosha Devadiga, Anita K McElroy, et al.Neuro-Oncology|September 30, 2025
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.Pageof 120